U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C33H41ClN2O9
Molecular Weight 645.14
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAPAQUISTAT ACETATE

SMILES

COC1=C(OC)C(=CC=C1)[C@H]2O[C@H](CC(=O)N3CCC(CC(O)=O)CC3)C(=O)N(CC(C)(C)COC(C)=O)C4=CC=C(Cl)C=C24

InChI

InChIKey=CMLUGNQVANVZHY-POURPWNDSA-N
InChI=1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1

HIDE SMILES / InChI

Molecular Formula C33H41ClN2O9
Molecular Weight 645.14
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

LAPAQUISTAT is a squalene synthase inhibitor. It was shown to lower cholesterol levels in several animal models. It was investigated for the treatment of diabetes and hypercholesterolemia, however, its development was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia.
2011-05-10
Squalene synthase inhibition: a novel target for the management of dyslipidemia.
2007-01
Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
2003-07
Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
2002-09-26
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 18:20:44 GMT 2025
Edited
by admin
on Mon Mar 31 18:20:44 GMT 2025
Record UNII
IUH3AY74O3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TAK 475
Preferred Name English
LAPAQUISTAT ACETATE
USAN  
USAN  
Official Name English
TAK-475
Code English
2-(1-(2-((3R,5S)-1-(3-ACETOXY-2,2-DIMETHYLPROPYL)-7-CHLORO-5-(2,3- DIMETHOXYPHENYL)-2-OXO-1,2,3,5-TETRAHYDROBENZO(E)(1,4)OXAZEPIN-3-YL)ACETYL)PIPERIDIN-4-YL)ACETIC ACID
Systematic Name English
TAK475
Code English
4-PIPERIDINEACETIC ACID, 1-(((3R,5S)-1-(3-(ACETYLOXY)-2,2-DIMETHYLPROPYL)-7-CHLORO-5-(2,3-DIMETHOXYPHENYL)-1,2,3,5-TETRAHYDRO-2-OXO-4,1-BENZOXAZEPIN-3-YL)ACETYL)-
Common Name English
LAPAQUISTAT ACETATE [USAN]
Common Name English
LAPAQUISTAT ACETATE [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29703
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
Code System Code Type Description
FDA UNII
IUH3AY74O3
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
PUBCHEM
9874248
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
CAS
189060-13-7
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
USAN
SS-96
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
EVMPD
SUB32261
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
ChEMBL
CHEMBL435224
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
EPA CompTox
DTXSID50432130
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
DRUG BANK
DB05317
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
NCI_THESAURUS
C81535
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
SMS_ID
100000124421
Created by admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
PRIMARY
Related Record Type Details
METABOLITE ACTIVE -> PARENT
In RD cells inhibited cholesterol biosynthesis
IC50
Related Record Type Details
ACTIVE MOIETY